Search Results
Mar 23, 2026, 16:24 ET NURSE CAPITAL WELCOMES HEALTHCARE INNOVATION VETERAN DAN WEBERG, PH.D. AS GENERAL PARTNER
multimedia:https://www.prnewswire.com/news-releases/nurse-capital-welcomes-healthcare-innovation-veteran-dan-weberg-phd-as-general-partner-302722462.htmlSOURCE
More news about: Nurse Capital
Mar 23, 2026, 14:00 ET Coalition of Provider and Patient Groups Urges Reforms on the Use of Prior Authorization for Therapy Services
requirements too often interfere with care that clinicians have already determined is medically necessary," states APTA President Kyle Covington, PT, DPT, PhD. "When patients are forced to wait for therapy, outcomes can suffer. Care delayed is care denied, and prior authorization practices must reflect
More news about: American Physical Therapy Association
Mar 23, 2026, 12:07 ET Cambridge Innovation Institute Announces Acquisition of Neurotech Reports
advance science and technology through innovation, so continuing that into the field of neurotechnology is a natural next step," says Benjamin Lakin, PhD, CEO of Cambridge Innovation Institute. "The neurotech field within healthcare continues to grow and will benefit from additional advancement via opportunities
More news about: Cambridge Innovation Institute
Mar 23, 2026, 11:46 ET Yale Surgeon Performs East Coast's First Shoulder Replacement with New Method
healthier lives," says Margaret McGovern, MD, PhD, CEO, Yale Medicine, deputy dean for Clinical Affairs, Yale School of Medicine, and executive vice president and chief physician officer, Yale New Haven
More news about: Yale School of Medicine
Mar 23, 2026, 11:11 ET RIFM Celebrates 60 Years of Fragrance Safety with Special Series of Trainee Awards at SOT 2026
Gretchen Ritacco, MS, to Nicole McNabb-Kelada, PhD (Marriott Grand Ballroom 9).Inhalation and Respiratory: Presented by RIFM Principal Scientist Nikaeta Sadekar, PhD, DABT, to Nicole McNabb-Kelada, PhD (San Diego Ballroom C).Risk Assessment:
More news about: Research Institute for Fragrance Materials
Mar 23, 2026, 10:07 ET Translational Insights Launches, Introducing a New Era in Translational Medicine
characterization, and validated clinical outcomes. With research operations in Boston, Nashville and Tijuana, TAM Global is a multidisciplinary team of 16 PhD scientists and 42 Medical doctors with a decade-long commitment to advancing regenerative medicine and cancer therapeutics. TAM Global is setting
More news about: The TAM Center
Mar 23, 2026, 09:55 ET Integral Molecular Appoints Cheryl Paes as Vice President of Commercial Strategy
LinkedInPress ContactIntegral MolecularSoma Banik, PhD, Director of Public [email protected]
More news about: Integral Molecular
Mar 23, 2026, 09:16 ET Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026
powerful, performance-evaluated AI models locally, securely, and at reliable high speeds while maintaining full control over data," said Megan Rothney PhD, VP of Product, Pictor Labs.On-Prem is inference-only, deploying performance-evaluated Pictor Labs models in a production environment. It does
More news about: PictorLabs
Mar 23, 2026, 09:07 ET PetSmart Charities Awards $3 Million in Grants to Local Shelters Ahead of National Adoption Week
relationships between people and their pets.Hill's is dedicated to pioneering research for dogs and cats through its team of 220+ veterinarians, PhD nutritionists, and food scientists, developing innovations in pet health.Hill's Prescription Diet therapeutic nutrition and Hill's Science
More news about: PetSmart Charities, Inc.
Mar 23, 2026, 09:05 ET CAPC 2026 Pet Parasite Forecast Just Released: Expanding Vectors, Emerging Hotspots and a New Era of Year-Round Risk
for broader public health as well."Vector-borne disease risk continues to expand – and not in straight lines," said Kathryn E. Reif, MSPH, PhD, Associate Professor in Parasitology at Auburn University, CAPC Board Member and lead author of the 2026 forecast. "Land use changes, pet travel,
More news about: Companion Animal Parasite Council
Mar 23, 2026, 09:04 ET 28bio's Endurance Study Meets Primary Endpoint, Showing CNS-3D Brain Organoids Predict Clinical Seizure Liability
agencies."These results show that CNS-3D Brain Organoids can predict human CNS outcomes far more accurately than traditional animal models," said Chris Butt, PhD VP of Technology at 28bio. "By enabling more reliable drugs to advance into first-in-human trials, this technology can reduce clinical failure across
More news about: 28bio
Mar 23, 2026, 08:30 ET Fast-Tracking IVT mRNA Candidate Selection Through Smarter RNA Design, Upcoming Webinar Hosted by Xtalks
Register to join Shambhavi Shubham, PhD, Senior Manager R&D,
More news about: Xtalks
Mar 23, 2026, 08:30 ET Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs, Upcoming Webinar Hosted by Xtalks
webinar to learn how to integrate comorbidity data with omics and knowledge graphs to generate testable biological hypotheses.Join Ruth Stoney, PhD, Senior Field Application Scientist,
More news about: Xtalks
Mar 23, 2026, 08:30 ET The Glomerular Revolution: Understanding the New Wave of Breakthroughs in Rare Kidney Diseases, Upcoming Webinar Hosted by Xtalks
learn how biomarker-informed strategies and trial execution choices can improve decision-making in rare kidney disease.Join Jonathan Barratt, PhD, FRCP, The Mayer Professor of Renal Medicine, University of Leicester; and Claudio Hegenberger, Vice President, Scientific and Medical Affairs,
More news about: Xtalks
Mar 23, 2026, 08:30 ET Improve Recruitment Outcomes Through More Diverse Clinical Trials, Upcoming Webinar Hosted by Xtalks
TransPerfect Life Sciences; Candy Vila, PharmD, MSPH, PhD, Sr. Director, Patient & Medical Affairs, Encoded; Deena Shaar, Founder & Principal, Athena IVD; Kim Cohee, MS, Executive Director, Patient Advocacy,
More news about: Xtalks
Mar 23, 2026, 07:30 ET HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
conference sharing the positive results of a study evaluating HyBryte™ versus Valchlor® (mechlorethamine) conducted by Brian Poligone, MD, PhD, Director of the Rochester Skin Lymphoma Medical Group and Principal Investigator for the comparability study. The official conference program can be
More news about: Soligenix
Mar 22, 2026, 10:00 ET IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial
2026Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Laura Prendergast, Managing Director, PhDA live audio webcast of the events will be available under the "Investors/Events" section of the IDEAYA website at
More news about: IDEAYA Biosciences, Inc.
Mar 21, 2026, 07:26 ET Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)
topline results from WU-KONG28 study represent an important advancement for treating patients with EGFR exon20ins NSCLC," said Prof. Caicun Zhou, MD, PhD of Shanghai East Hospital and the principal investigator of the study. "ZEGFROVY is currently the only single-agent, small-molecule targeted therapy
More news about: Dizal
Mar 20, 2026, 11:01 ET Researchers Identify Older Adults Most at Risk of Heat-Related Illness
adults.Along with Drs. Azan and Horwitz, NYU Langone researchers involved in the study were Evan Siau, MD, MPH; Jeremy Lu, MS; Cassandra Thiel, PhD; and Simon A. Jones, PhD.Other study co-investigators were Genevieve S. Silva, MD and Katie E. Lichter, MD at the University of California, San Francisco.About
More news about: NYU Langone Health System
Mar 20, 2026, 10:00 ET Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
Safety, and Baseline Severity–Dependent Treatment Response in Moderate-to-Severe Atopic Dermatitis"Presenter: Raj Chovatiya, MD, PhD, MSCI, FAADPresentation Date and Time: Saturday, March 28, 2026 from 11:40 AM-11:45 AM MSTLocation: Colorado Convention Center, Lobby
More news about: Nektar Therapeutics
Mar 20, 2026, 08:44 ET Just Good Soil Brings Regenerative Agriculture Science to Home Gardeners with AI-Powered Soil Testing
strengthen root systems and improve plant resilience under environmental stress."Nutrient dense food begins with healthy soil." said Chris Cerveny, PhD, Co-Founder and Soil Scientist. "When you invest in microbial diversity and nutrient cycling, you change the trajectory of your garden. We are bringing
More news about: Just Good Soil
Mar 20, 2026, 08:30 ET Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
Matthew Oberley, MD, PhD, Senior Vice President, Chief Clinical Officer and Pathologist-in-Chief at Caris. "By integrating AI-driven tissue‑of‑origin predictions with comprehensive
More news about: Caris Life Sciences
Mar 20, 2026, 08:24 ET Wayfinder Family Services Hosts Panel on AI and the Future of Human Services
Age of AI. The panel featured Maja Matarić, PhD, a chaired and distinguished professor at the University of Southern California and a pioneer in socially assistive robotics, and Wayfinder Family Services Chief Operating Officer Dawn Vo-Jutabha, PhD. Pete Kinser, co-founder and managing partner of
More news about: Wayfinder Family Services
Mar 20, 2026, 07:30 ET Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
diseases."AI is at the core of everything we do — not as a research tool, but as a production engine for real therapeutic programs," said Jian Peng, PhD, Founder and CEO of Earendil Labs. "This financing allows us to operate at a fundamentally different scale, advancing multiple programs toward the clinic
More news about: Earendil Labs
Mar 20, 2026, 05:26 ET Persistent Appoints Hari S. Abhyankar as Executive Vice President and Global Head of Private Equity and Professional Services
he built and led analytics, digital strategy and data-driven marketing organizations serving global technology and enterprise clients. Hari holds a PhD in Operations Management from the MIT Sloan School of Management.Sandeep Kalra, Chief Executive Officer and Executive Director, Persistent"Private
More news about: Persistent Systems